Skip to main content
Overview
News
Events & Presentations
Events
Presentations
IRA Commentary
Halozyme Statement on Proposed Rule for IPAY 2029
Halozyme Letter to CMS on IRA IPAY 2028
Comparison Medicare Expenditure for SC versus IV Drugs
Patient Experience: SC Treatment
Royalty Duration
Stock Info
Stock Information
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Leadership Team
Board of Directors
Commitment to ESG
Resources
Investor FAQs
Email Alerts
Contact Us
Skip to main content
Event Details
Overview
News
Events & Presentations
Events
Presentations
IRA Commentary
Halozyme Statement on Proposed Rule for IPAY 2029
Halozyme Letter to CMS on IRA IPAY 2028
Comparison Medicare Expenditure for SC versus IV Drugs
Patient Experience: SC Treatment
Royalty Duration
Stock Info
Stock Information
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Leadership Team
Board of Directors
Commitment to ESG
Resources
Investor FAQs
Email Alerts
Contact Us
Halozyme 4Q and FY 2025 Financial and Operating Results Conference Call
February 17, 2026 4:30 PM ET
Webcast
(opens in new window)
Press Release
(opens in new window)
Presentation
(opens in new window)